BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6874951)

  • 41. Use of isoproterenol during programmed ventricular stimulation in patients with coronary artery disease and nonsustained ventricular tachycardia.
    Niebauer M; Daoud E; Goyal R; Chan KK; Harvey M; Bogun F; Castellani M; Man KC; Strickberger SA; Morady F
    Am Heart J; 1996 Mar; 131(3):516-8. PubMed ID: 8604631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initiation of ventricular tachycardia by interpolated ventricular premature depolarizations.
    Friedman PL; Brugada P; Kuck KH; Bär FW; Wellens HJ
    Am J Cardiol; 1981 Nov; 48(5):967-72. PubMed ID: 7304444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of verapamil in ventricular tachycardias. An experimental and clinical study.
    De Micheli A; Medrano GA; Iturralde P; Casanova JM
    Acta Cardiol; 1997; 52(1):1-15. PubMed ID: 9139517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
    Kasanuki H; Ohnishi S; Hirosawa K
    Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia.
    Wellens HJ; Bär FW; Lie KI; Düren DR; Dohmen HJ
    Am J Cardiol; 1977 Oct; 40(4):579-85. PubMed ID: 910721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction and the possible mechanism of ventricular tachycardia after catheter ablation with direct current shocks in dogs.
    Ishibashi H; Fu L; Namiki T; Sekiguchi A; Sagara K; Kato K
    Eur Heart J; 1993 Aug; 14(8):1132-6. PubMed ID: 8404945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of an entrainment protocol on ouabain-induced ventricular tachycardia.
    Vos MA; Gorgels AP; Leunissen-Beekman JD; Brugada P; Wellens HJ
    Pacing Clin Electrophysiol; 1989 Sep; 12(9):1485-93. PubMed ID: 2476777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Right ventricular tachycardia: clinical and electrophysiologic characteristics.
    Buxton AE; Waxman HL; Marchlinski FE; Simson MB; Cassidy D; Josephson ME
    Circulation; 1983 Nov; 68(5):917-27. PubMed ID: 6137291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophysiologic effects of ethmozin in patients with ventricular tachycardia.
    Mann DE; Luck JC; Herre JM; Magro SA; Yepsen SC; Griffin JC; Pratt CM; Wyndham CR
    Am Heart J; 1984 Apr; 107(4):674-9. PubMed ID: 6367405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent ventricular tachycardia responsive to verapamil.
    Klein GJ; Millman PJ; Yee R
    Pacing Clin Electrophysiol; 1984 Nov; 7(6 Pt 1):938-48. PubMed ID: 6209631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction and termination of triggered activity by pacing in isolated canine Purkinje fibers.
    Moak JP; Rosen MR
    Circulation; 1984 Jan; 69(1):149-62. PubMed ID: 6689639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained ventricular tachycardia responsive to verapamil in patients with hypertrophic cardiomyopathy. Clinical and electrophysiological assessment of drug efficacy.
    Miyajima S; Aizawa Y; Suzuki K; Satoh M; Niwano S; Ebe K; Fujita T; Ishiguro J; Hirokawa Y; Shibata A
    Jpn Heart J; 1989 Mar; 30(2):241-9. PubMed ID: 2724542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil.
    Maggioni AP; Cavalli A; Tusa M; Volpi A
    Acta Cardiol; 1986; 41(6):443-9. PubMed ID: 3492843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol.
    Buxton AE; Waxman HL; Marchlinski FE; Josephson ME
    Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Verapamil reduces tachycardia-induced electrical remodeling of the atria.
    Tieleman RG; De Langen C; Van Gelder IC; de Kam PJ; Grandjean J; Bel KJ; Wijffels MC; Allessie MA; Crijns HJ
    Circulation; 1997 Apr; 95(7):1945-53. PubMed ID: 9107184
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of repetitive monomorphic ventricular tachycardia.
    Lerman BB; Stein K; Engelstein ED; Battleman DS; Lippman N; Bei D; Catanzaro D
    Circulation; 1995 Aug; 92(3):421-9. PubMed ID: 7634458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length.
    Denker S; Lehmann M; Mahmud R; Gilbert C; Akhtar M
    Am J Cardiol; 1984 Feb; 53(4):508-15. PubMed ID: 6198893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The response of digitalized canine ventricle to programmed stimulation: a study on triggered activity arrhythmias in the whole heart.
    Iinuma H; Sekiguchi A; Kato K
    Pacing Clin Electrophysiol; 1989 Aug; 12(8):1331-46. PubMed ID: 2476757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying sites for catheter ablation of ventricular tachycardia.
    Stevenson WG; Sager P; Nademanee K; Hassan H; Middlekauff HR; Saxon LA; Wiener I
    Herz; 1992 Jun; 17(3):158-70. PubMed ID: 1639335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.